These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32994455)

  • 81. Targeting zero catheter-related bloodstream infections in pediatric intensive care unit: a retrospective matched case-control study.
    Biasucci DG; Pittiruti M; Taddei A; Picconi E; Pizza A; Celentano D; Piastra M; Scoppettuolo G; Conti G
    J Vasc Access; 2018 Mar; 19(2):119-124. PubMed ID: 29148002
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Our method of povidone-iodine ointment and gauze dressings reduced catheter-related infection in serious cases.
    Fukunaga A; Naritaka H; Fukaya R; Tabuse M; Nakamura T
    Dermatology; 2006; 212 Suppl 1():47-52. PubMed ID: 16490975
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A review of risk factors for catheter-related bloodstream infection caused by percutaneously inserted, noncuffed central venous catheters: implications for preventive strategies.
    Safdar N; Kluger DM; Maki DG
    Medicine (Baltimore); 2002 Nov; 81(6):466-79. PubMed ID: 12441903
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Dressing and securement for central venous access devices (CVADs): A Cochrane systematic review.
    Ullman AJ; Cooke ML; Mitchell M; Lin F; New K; Long DA; Mihala G; Rickard CM
    Int J Nurs Stud; 2016 Jul; 59():177-96. PubMed ID: 27222463
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Tegaderm™ CHG dressing significantly improves catheter-related infection rate in hemodialysis patients.
    Righetti M; Palmieri N; Bracchi O; Prencipe M; Bruschetta E; Colombo F; Brenna I; Stefani F; Amar K; Scalia A; Conte F
    J Vasc Access; 2016 Sep; 17(5):417-422. PubMed ID: 27516139
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis.
    Veenstra DL; Saint S; Saha S; Lumley T; Sullivan SD
    JAMA; 1999 Jan; 281(3):261-7. PubMed ID: 9918482
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Effect of chlorhexidine/silver sulfadiazine-impregnated central venous catheters in an intensive care unit with a low blood stream infection rate after implementation of an educational program: a before-after trial.
    Schuerer DJ; Zack JE; Thomas J; Borecki IB; Sona CS; Schallom ME; Venker M; Nemeth JL; Ward MR; Verjan L; Warren DK; Fraser VJ; Mazuski JE; Boyle WA; Buchman TG; Coopersmith CM
    Surg Infect (Larchmt); 2007 Aug; 8(4):445-54. PubMed ID: 17883361
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Prevention of hospital-acquired bloodstream infections through chlorhexidine gluconate-impregnated washcloth bathing in intensive care units: a systematic review and meta-analysis of randomised crossover trials.
    Afonso E; Blot K; Blot S
    Euro Surveill; 2016 Nov; 21(46):. PubMed ID: 27918269
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Chlorhexidine 2% and choice of transparent dressing increase skin reactions at central venous catheter insertion sites.
    Loewenthal M; Dobson P; Boyle M
    Am J Infect Control; 2016 Dec; 44(12):1712-1714. PubMed ID: 27544790
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Effect of skin antiseptic solutions on the incidence of catheter-related bloodstream infection: a systematic review and network meta-analysis.
    Masuyama T; Yasuda H; Sanui M; Lefor AK
    J Hosp Infect; 2021 Apr; 110():156-164. PubMed ID: 33529623
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Chlorhexidine gluconate-impregnated central-line dressings and necrosis in complicated skin disorder patients.
    Wall JB; Divito SJ; Talbot SG
    J Crit Care; 2014 Dec; 29(6):1130.e1-4. PubMed ID: 25035049
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The use of rifampicin-miconazole-impregnated catheters reduces the incidence of femoral and jugular catheter-related bacteremia.
    Lorente L; Lecuona M; Ramos MJ; Jiménez A; Mora ML; Sierra A
    Clin Infect Dis; 2008 Nov; 47(9):1171-5. PubMed ID: 18808356
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Chlorhexidine-Impregnated Dressings and Prevention of Catheter-Associated Bloodstream Infections in a Pediatric Intensive Care Unit.
    Düzkaya DS; Sahiner NC; Uysal G; Yakut T; Çitak A
    Crit Care Nurse; 2016 Dec; 36(6):e1-e7. PubMed ID: 27908954
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Prevention of intravascular catheter-related infection with newer chlorhexidine-silver sulfadiazine-coated catheters: a randomized controlled trial.
    Brun-Buisson C; Doyon F; Sollet JP; Cochard JF; Cohen Y; Nitenberg G
    Intensive Care Med; 2004 May; 30(5):837-43. PubMed ID: 15060765
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Chlorhexidine and gauze and tape dressings for central venous catheters: a randomized clinical trial.
    Pedrolo E; Danski MT; Vayego SA
    Rev Lat Am Enfermagem; 2014 Oct; 22(5):764-71. PubMed ID: 25493671
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Central venous catheter infection in adults in acute hospital settings.
    Jones CA
    Br J Nurs; 2006 Apr 13-26; 15(7):362, 364-8. PubMed ID: 16723935
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Mid-term analysis of prospective cohort study of rivaroxaban in preventing CRT in breast cancer].
    Sang D; Fan SM; Li SY; Zhang JT; Wang HM; Zhao XH; Zheng LJ; Liang P; Xi GB; Zhao LM; Zhang YR; Yuan P
    Zhonghua Zhong Liu Za Zhi; 2024 Mar; 46(3):256-262. PubMed ID: 38494772
    [No Abstract]   [Full Text] [Related]  

  • 98. Chlorhexidine gluconate or polyhexamethylene biguanide disc dressing to reduce the incidence of central-line-associated bloodstream infection: a feasibility randomized controlled trial (the CLABSI trial).
    Webster J; Larsen E; Marsh N; Choudhury A; Harris P; Rickard CM
    J Hosp Infect; 2017 Jul; 96(3):223-228. PubMed ID: 28526171
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers.
    Kao HF; Chen IC; Hsu C; Chang SY; Chien SF; Chen YC; Hu FC; Yang JC; Cheng AL; Yeh KH
    Support Care Cancer; 2014 May; 22(5):1189-97. PubMed ID: 24384684
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial.
    Rupp ME; Lisco SJ; Lipsett PA; Perl TM; Keating K; Civetta JM; Mermel LA; Lee D; Dellinger EP; Donahoe M; Giles D; Pfaller MA; Maki DG; Sherertz R
    Ann Intern Med; 2005 Oct; 143(8):570-80. PubMed ID: 16230723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.